206 related articles for article (PubMed ID: 33163949)
1. Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area.
Amaddeo G; Brustia R; Allaire M; Lequoy M; Hollande C; Regnault H; Blaise L; Ganne-Carrié N; Séror O; Larrey E; Lim C; Scatton O; El Mouhadi S; Ozenne V; Paye F; Balladur P; Dohan A; Massault PP; Pol S; Dioguardi Burgio M; Vilgrain V; Sepulveda A; Cauchy F; Luciani A; Sommacale D; Leroy V; Roudot-Thoraval F; Bouattour M; Nault JC;
JHEP Rep; 2021 Feb; 3(1):100199. PubMed ID: 33163949
[TBL] [Abstract][Full Text] [Related]
2. Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?
Brustia R; Bouattour M; Allaire M; Lequoy M; Hollande C; Regnault H; Blaise L; Ganne-Carrié N; Vilgrain V; Larrey E; Lim C; Scatton O; Mouhadi SE; Ozenne V; Paye F; Balladur P; Dohan A; Massault PP; Pol S; Dioguardi Burgio M; Sepulveda A; Cauchy F; Luciani A; Sommacale D; Leroy V; Calderaro J; Roudot-Thoraval F; Nault JC; Amaddeo G;
Ann Hepatol; 2023; 28(6):101141. PubMed ID: 37468096
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
[TBL] [Abstract][Full Text] [Related]
4. Assessing the impact of COVID-19 on liver cancer management (CERO-19).
Muñoz-Martínez S; Sapena V; Forner A; Nault JC; Sapisochin G; Rimassa L; Sangro B; Bruix J; Sanduzzi-Zamparelli M; Hołówko W; El Kassas M; Mocan T; Bouattour M; Merle P; Hoogwater FJH; Alqahtani SA; Reeves HL; Pinato DJ; Giorgakis E; Meyer T; Villadsen GE; Wege H; Salati M; Mínguez B; Di Costanzo GG; Roderburg C; Tacke F; Varela M; Galle PR; Alvares-da-Silva MR; Trojan J; Bridgewater J; Cabibbo G; Toso C; Lachenmayer A; Casadei-Gardini A; Toyoda H; Lüdde T; Villani R; Matilla Peña AM; Guedes Leal CR; Ronzoni M; Delgado M; Perelló C; Pascual S; Lledó JL; Argemi J; Basu B; da Fonseca L; Acevedo J; Siebenhüner AR; Braconi C; Meyers BM; Granito A; Sala M; Rodríguez-Lope C; Blaise L; Romero-Gómez M; Piñero F; Gomez D; Mello V; Pinheiro Alves RC; França A; Branco F; Brandi G; Pereira G; Coll S; Guarino M; Benítez C; Anders MM; Bandi JC; Vergara M; Calvo M; Peck-Radosavljevic M; García-Juárez I; Cardinale V; Lozano M; Gambato M; Okolicsanyi S; Morales-Arraez D; Elvevi A; Muñoz AE; Lué A; Iavarone M; Reig M
JHEP Rep; 2021 Jun; 3(3):100260. PubMed ID: 33644725
[TBL] [Abstract][Full Text] [Related]
5. Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis.
Nahon P; Najean M; Layese R; Zarca K; Segar LB; Cagnot C; Ganne-Carrié N; N'Kontchou G; Pol S; Chaffaut C; Carrat F; Ronot M; Audureau E; Durand-Zaleski I; ; ; ;
JHEP Rep; 2022 Jan; 4(1):100390. PubMed ID: 34977518
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the best treatment for multifocal hepatocellular carcinoma: A propensity score-matched analysis.
Risaliti M; Bartolini I; Campani C; Arena U; Xodo C; Adotti V; Rosi M; Taddei A; Muiesan P; Amedei A; Batignani G; Marra F
World J Gastroenterol; 2022 Aug; 28(29):3981-3993. PubMed ID: 36157535
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
Vilgrain V; Pereira H; Assenat E; Guiu B; Ilonca AD; Pageaux GP; Sibert A; Bouattour M; Lebtahi R; Allaham W; Barraud H; Laurent V; Mathias E; Bronowicki JP; Tasu JP; Perdrisot R; Silvain C; Gerolami R; Mundler O; Seitz JF; Vidal V; Aubé C; Oberti F; Couturier O; Brenot-Rossi I; Raoul JL; Sarran A; Costentin C; Itti E; Luciani A; Adam R; Lewin M; Samuel D; Ronot M; Dinut A; Castera L; Chatellier G;
Lancet Oncol; 2017 Dec; 18(12):1624-1636. PubMed ID: 29107679
[TBL] [Abstract][Full Text] [Related]
8. International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria.
Degroote H; Piñero F; Costentin C; Notarpaolo A; Boin IF; Boudjema K; Baccaro C; Chagas AL; Bachellier P; Ettorre GM; Poniachik J; Muscari F; Di Benedetto F; Duque SH; Salame E; Cillo U; Gadano A; Vanlemmens C; Fagiuoli S; Rubinstein F; Burra P; Cherqui D; Silva M; Van Vlierberghe H; Duvoux C;
JHEP Rep; 2021 Oct; 3(5):100331. PubMed ID: 34485882
[TBL] [Abstract][Full Text] [Related]
9. Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2.
Kudo M; Galle PR; Brandi G; Kang YK; Yen CJ; Finn RS; Llovet JM; Assenat E; Merle P; Chan SL; Palmer DH; Ikeda M; Yamashita T; Vogel A; Huang YH; Abada PB; Yoshikawa R; Shinozaki K; Wang C; Widau RC; Zhu AX
JHEP Rep; 2021 Apr; 3(2):100215. PubMed ID: 33392490
[TBL] [Abstract][Full Text] [Related]
10. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
[TBL] [Abstract][Full Text] [Related]
11. Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension.
Azoulay D; Ramos E; Casellas-Robert M; Salloum C; Lladó L; Nadler R; Busquets J; Caula-Freixa C; Mils K; Lopez-Ben S; Figueras J; Lim C
JHEP Rep; 2021 Feb; 3(1):100190. PubMed ID: 33294830
[TBL] [Abstract][Full Text] [Related]
12. Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma.
Ricke J; Klümpen HJ; Amthauer H; Bargellini I; Bartenstein P; de Toni EN; Gasbarrini A; Pech M; Peck-Radosavljevic M; Popovič P; Rosmorduc O; Schott E; Seidensticker M; Verslype C; Sangro B; Malfertheiner P
J Hepatol; 2019 Dec; 71(6):1164-1174. PubMed ID: 31421157
[TBL] [Abstract][Full Text] [Related]
13. Impact of COVID-19 on Hepatocellular Carcinoma Management: A Multicountry and Region Study.
Gandhi M; Ling WH; Chen CH; Lee JH; Kudo M; Chanwat R; Strasser SI; Xu Z; Lai SH; Chow PK
J Hepatocell Carcinoma; 2021; 8():1159-1167. PubMed ID: 34589445
[TBL] [Abstract][Full Text] [Related]
14. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
Han K; Kim JH
World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
[TBL] [Abstract][Full Text] [Related]
15. Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States.
Lee IS; Okumura K; Misawa R; Sogawa H; Veillette G; John D; Diflo T; Nishida S; Dhand A
World J Hepatol; 2023 Apr; 15(4):554-563. PubMed ID: 37206654
[TBL] [Abstract][Full Text] [Related]
16. Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Single Turkey Center Study.
Bilican G; Özgül S; Ekmen N; Moral K; Küçük H; Dumanlı S; Abiyev A; Karakan T; Kekilli M
J Gastrointestin Liver Dis; 2023 Sep; 32(3):367-370. PubMed ID: 37774229
[TBL] [Abstract][Full Text] [Related]
17. TACE and conformal radiotherapy
Féray C; Campion L; Mathurin P; Archambreaud I; Mirabel X; Bronowicki JP; Rio E; Perret C; Mineur L; Oberti F; Touchefeu Y; Gournay J; Regnault H; Edeline J; Rode A; Hillion P; Blanc JF; Khac EN; Azoulay D; Luciani A; Preglisasco AG; Faurel-Paul E; Auble H; Mornex F; Merle P
JHEP Rep; 2023 Apr; 5(4):100689. PubMed ID: 36937990
[TBL] [Abstract][Full Text] [Related]
18. Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.
Costentin CE; Layese R; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Letouzé E; Imbeaud S; Zucman-Rossi J; Audureau E; Roudot-Thoraval F; Nahon P;
Gastroenterology; 2018 Aug; 155(2):431-442.e10. PubMed ID: 29729258
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive imaging criteria for the diagnosis of hepatocellular carcinoma in non-cirrhotic patients with chronic hepatitis B.
Moctezuma-Velázquez C; Lewis S; Lee K; Amodeo S; Llovet JM; Schwartz M; Abraldes JG; Villanueva A
JHEP Rep; 2021 Dec; 3(6):100364. PubMed ID: 34712933
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma.
Waidmann O; Köberle V; Bettinger D; Trojan J; Zeuzem S; Schultheiß M; Kronenberger B; Piiper A
J Hepatol; 2013 Oct; 59(4):769-79. PubMed ID: 23792028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
